<DOC>
	<DOCNO>NCT01330615</DOCNO>
	<brief_summary>Aims : The investigator main purpose ass efficacy analgesia provide topical lidocaine/prilocaine cream 5 % ( EMLA ) ® par plantar wart prior application liquid nitrogen cryotherapy adult .</brief_summary>
	<brief_title>Efficacy Trial Eutectic Lidocaine/Prilocaine Cream 5 % ( EMLA ) Analgesia Prior Cryotherapy Verrucae Plantaris</brief_title>
	<detailed_description>Methodology : The study single-centre , double-blind , randomize , placebo-controlled , parallel-group trial one visit . The investigator plan include least 64 patient 4 month . Adult patient ( least 21 year old ) diagnose plantar wart potential subject study . Once potential subject identify , field investigator ass him/her eligibility enter study . Then , potential subject provide full adequate verbal write information nature , purpose , possible risk benefit study . If subject agree enroll study , sign informed consent obtain him/her . All patient randomly assign computer-generated randomization sequence receive either eutectic lidocaine/prilocaine cream ( EMLA ) ® 5 % placebo 60 min prior application cryotherapy . The plantar wart par shape blade apply EMLA®or placebo cream . Based randomization , designate dermatology laboratory technician apply either EMLA® cream 5 % placebo cream wart lesion . The cream apply thick layer wart surround 1 2 mm leave 60 minute occlusion Tegaderm dressing . The cream remove , liquid cryotherapy apply use cryospray . The lesion treat double freeze-thaw cycle . The end point freeze complete ice-ball cover lesion 1-2mm peripheral extension . The study involve one treatment either placebo EMLA® cream 5 % follow cryotherapy described . No analgesic EMLA® cream 5 % placebo allow least 2 hour prior cryotherapy . A 100 mm visual analogue pain scale ( VAS ) use denote pain severity range `` pain '' ( 0 mm ) `` bad possible pain '' ( 100 mm ) . The patient choose distance `` pain '' anchor close pain experience cryotherapy wart removal . Pain evaluate participant use self-administered VAS immediately cryotherapy treatment . Potential Benefits : The potential benefit : 1 . The patient may experience less pain application cryotherapy . 2 . The application local anesthetic cream may possibly increase effectiveness cryotherapy . Potential Risks : EMLA cream® know relatively safe minimal side effect . The common side effect would local irritation skin e.g . redness , itchiness reversible removal cream . Very rarely ( &lt; 1000 ) , severe allergic reaction occur application EMLA cream® ( AstraZeneca information brochure ) .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<criteria>1 . Adult patient ( least 21 year old ) plantar warts 2 . They must agree liquid nitrogen cryotherapy treatment plantar warts 3 . The patient capable assess pain use visual analogue pain scale ( VAS ) 1 . Patients previously use EMLA cream® prior cryotherapy warts 2 . Known allergic sensitivity EMLA cream® amide type local anaesthetic . 3 . Patients sensory peripheral neuropathy low limb .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>EMLA</keyword>
	<keyword>plantar wart</keyword>
	<keyword>cryotherapy</keyword>
</DOC>